Flagship explainer
What drives Profound Medical Corp.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$42.6M | FY2025 |
| |
| Income before tax | −$42.3M | FY2025 |
|
| Operating income | −$41.3M | FY2025 |
|
| $16.1M | FY2025 |
| |
| Ending assets | $77.5M | FY2025 |
|
| Beginning assets | $70.2M | FY2024 |
|
| $66.4M | FY2025 |
| |
| $60.4M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001104659-26-024153
- SEC filingFiling detailsAccession 0001410578-25-000300